Page last updated: 2024-08-25

9-aminocamptothecin and Astrocytoma, Grade IV

9-aminocamptothecin has been researched along with Astrocytoma, Grade IV in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahluwalia, MS; Barnett, GH; Cohen, BH; Farray, D; Peereboom, DM; Snyder, J; Suh, JH	1
Fisher, JD; Grossman, S; Piantadosi, S	1
Chen, TL; Fisher, J; Gregory, R; Grochow, LB; Grossman, SA; Hochberg, F; Kim, L; Piantadosi, S	1
Fisher, JD; Glantz, M; Grossman, SA; Hochberg, F; Mikkelsen, T; Piantadosi, S	1

Trials

2 trial(s) available for 9-aminocamptothecin and Astrocytoma, Grade IV

Article	Year
Pre-irradiation 9-amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme. Investigational new drugs, 2006, Volume: 24, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Treatment Outcome	2006
Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy. Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:2 Topics: Adolescent; Adult; Aged; Anticonvulsants; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Camptothecin; Drug Administration Schedule; Drug Interactions; Glioblastoma; Humans; Middle Aged	1998

Article

Year

Pre-irradiation 9-amino [20s] camptothecin (9-AC) in patients with newly diagnosed glioblastoma multiforme.

Investigational new drugs, 2006, Volume: 24, Issue:3

Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Combined Modality Therapy; Female; Glioblastoma; Humans; Male; Middle Aged; Treatment Outcome

2006

Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants. NABTT CNS Consortium. The New Approaches to Brain Tumor Therapy.

Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:2

Topics: Adolescent; Adult; Aged; Anticonvulsants; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Camptothecin; Drug Administration Schedule; Drug Interactions; Glioblastoma; Humans; Middle Aged

1998

Other Studies

2 other study(ies) available for 9-aminocamptothecin and Astrocytoma, Grade IV

Article	Year
Practical implementation of a modified continual reassessment method for dose-finding trials. Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:6 Topics: Antineoplastic Agents; Brain Neoplasms; Camptothecin; Clinical Trials, Phase I as Topic; Dose-Response Relationship, Drug; Glioblastoma; Humans; Models, Theoretical; Neoplasm Recurrence, Local; Reproducibility of Results	1998
Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma. NABTT CNS Consortium. Neuro-oncology, 2000, Volume: 2, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Female; Glioblastoma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Treatment Failure	2000

Article

Year

Practical implementation of a modified continual reassessment method for dose-finding trials.

Cancer chemotherapy and pharmacology, 1998, Volume: 41, Issue:6

Topics: Antineoplastic Agents; Brain Neoplasms; Camptothecin; Clinical Trials, Phase I as Topic; Dose-Response Relationship, Drug; Glioblastoma; Humans; Models, Theoretical; Neoplasm Recurrence, Local; Reproducibility of Results

1998

Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma. NABTT CNS Consortium.

Neuro-oncology, 2000, Volume: 2, Issue:1

Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Camptothecin; Female; Glioblastoma; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Retreatment; Treatment Failure

2000